Abstract

After a myocardial infarction (MI), a dense collagen scar is formed that initially prevents the heart from rupturing. However, after the scar is formed, collagen deposits accumulate and the extracellular matrix (ECM) is remodeled in the viable areas of the heart, distal from the site of injury, which causes the entire organ to vstiffen in a process called cardiac fibrosis (CF). CF often contributes to the development of heart failure (HF) which is a major clinical problem in Canada. Cardiac fibroblasts (FBs) provide structural support and remodel the ECM in the healthy heart, but after an MI, FBs become activated, proliferate, and adopt a myofibroblast (MF) phenotype. MFs can continue to produce ECM long after they become activated which leads to CF and ultimately HF. Two transcription factors that have been identified as potential contributors to CF are zinc finger E‐box binding homeobox 1 and 2 (ZEB1/2). ZEB1 and ZEB2 are essential for epithelial‐mesenchymal transition (EMT) and, previous studies in our lab have shown that ZEB2 is also directly involved with FB activation. Based on other research we hypothesize that ZEB1 may also regulate FB activation and be functionally redundant with ZEB2. Our initial results show that ZEB1 protein and RNA levels both increase as FBs convert to MFs. By comparing samples at varying time points we have increased our understanding of the FB to MF activation process. This study show that ZEB1 may be involved in the fibrotic process and further analysis will determine the extent of its involvement.Support or Funding InformationSupported by a grant from NSERC and from the St. Boniface Hospital Foundation Research without Borders initiative.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call